Cargando…
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. Ho...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Brieflands
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191225/ https://www.ncbi.nlm.nih.gov/pubmed/35765502 http://dx.doi.org/10.5812/ijpr.123947 |
| _version_ | 1784725968452059136 |
|---|---|
| author | Mirenayat, Maryam Sadat Abedini, Atefeh Kiani, Arda Eslaminejad, Alireza Adimi naghan, Parisa Malekmohammad, Majid Heshmatnia, Jalal Nadji, Seyed Alireza Idani, Esmaeil Zahiri, Reyhaneh Lookzadeh, Somayeh Sheikhzade, Hakimeh Dastan, Farzaneh Porabdollah Toutkaboni, Mihan Rezaei, Mitra Sadat Askari, Elham Tabarsi, Payam Marjani, Majid Moniri, Afshin Hashemian, Seyed Mohammad Reza Farzanegan, Behrooz Abtahian, Zahra Yassari, Fatemeh Mansouri, Nazanin Mansouri, Davood Vasheghani, Maryam Mansourafshar, Babak Mokhber Dezfoli, Mojtaba Soleimani, Salman Seifi, Sharareh Naghashzadeh, Farah Fakharian, Atefeh Varahram, Mohammad Jamaati, Hamidreza Zali, Alireza Velayati, Ali Akbar |
| author_facet | Mirenayat, Maryam Sadat Abedini, Atefeh Kiani, Arda Eslaminejad, Alireza Adimi naghan, Parisa Malekmohammad, Majid Heshmatnia, Jalal Nadji, Seyed Alireza Idani, Esmaeil Zahiri, Reyhaneh Lookzadeh, Somayeh Sheikhzade, Hakimeh Dastan, Farzaneh Porabdollah Toutkaboni, Mihan Rezaei, Mitra Sadat Askari, Elham Tabarsi, Payam Marjani, Majid Moniri, Afshin Hashemian, Seyed Mohammad Reza Farzanegan, Behrooz Abtahian, Zahra Yassari, Fatemeh Mansouri, Nazanin Mansouri, Davood Vasheghani, Maryam Mansourafshar, Babak Mokhber Dezfoli, Mojtaba Soleimani, Salman Seifi, Sharareh Naghashzadeh, Farah Fakharian, Atefeh Varahram, Mohammad Jamaati, Hamidreza Zali, Alireza Velayati, Ali Akbar |
| author_sort | Mirenayat, Maryam Sadat |
| collection | PubMed |
| description | More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. However, due to the novel nature of the disease and the emergence of new variants, medical teams' updating medical information and drug prescribing guidelines should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients. |
| format | Online Article Text |
| id | pubmed-9191225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Brieflands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91912252022-06-27 National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 Mirenayat, Maryam Sadat Abedini, Atefeh Kiani, Arda Eslaminejad, Alireza Adimi naghan, Parisa Malekmohammad, Majid Heshmatnia, Jalal Nadji, Seyed Alireza Idani, Esmaeil Zahiri, Reyhaneh Lookzadeh, Somayeh Sheikhzade, Hakimeh Dastan, Farzaneh Porabdollah Toutkaboni, Mihan Rezaei, Mitra Sadat Askari, Elham Tabarsi, Payam Marjani, Majid Moniri, Afshin Hashemian, Seyed Mohammad Reza Farzanegan, Behrooz Abtahian, Zahra Yassari, Fatemeh Mansouri, Nazanin Mansouri, Davood Vasheghani, Maryam Mansourafshar, Babak Mokhber Dezfoli, Mojtaba Soleimani, Salman Seifi, Sharareh Naghashzadeh, Farah Fakharian, Atefeh Varahram, Mohammad Jamaati, Hamidreza Zali, Alireza Velayati, Ali Akbar Iran J Pharm Res Methods Article More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. However, due to the novel nature of the disease and the emergence of new variants, medical teams' updating medical information and drug prescribing guidelines should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients. Brieflands 2022-03-30 /pmc/articles/PMC9191225/ /pubmed/35765502 http://dx.doi.org/10.5812/ijpr.123947 Text en Copyright © 2022, Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
| spellingShingle | Methods Article Mirenayat, Maryam Sadat Abedini, Atefeh Kiani, Arda Eslaminejad, Alireza Adimi naghan, Parisa Malekmohammad, Majid Heshmatnia, Jalal Nadji, Seyed Alireza Idani, Esmaeil Zahiri, Reyhaneh Lookzadeh, Somayeh Sheikhzade, Hakimeh Dastan, Farzaneh Porabdollah Toutkaboni, Mihan Rezaei, Mitra Sadat Askari, Elham Tabarsi, Payam Marjani, Majid Moniri, Afshin Hashemian, Seyed Mohammad Reza Farzanegan, Behrooz Abtahian, Zahra Yassari, Fatemeh Mansouri, Nazanin Mansouri, Davood Vasheghani, Maryam Mansourafshar, Babak Mokhber Dezfoli, Mojtaba Soleimani, Salman Seifi, Sharareh Naghashzadeh, Farah Fakharian, Atefeh Varahram, Mohammad Jamaati, Hamidreza Zali, Alireza Velayati, Ali Akbar National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
| title | National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
| title_full | National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
| title_fullStr | National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
| title_full_unstemmed | National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
| title_short | National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
| title_sort | national research institute of tuberculosis and lung disease (nritld) protocol for the treatment of patients with covid-19 |
| topic | Methods Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191225/ https://www.ncbi.nlm.nih.gov/pubmed/35765502 http://dx.doi.org/10.5812/ijpr.123947 |
| work_keys_str_mv | AT mirenayatmaryamsadat nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT abediniatefeh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT kianiarda nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT eslaminejadalireza nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT adiminaghanparisa nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT malekmohammadmajid nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT heshmatniajalal nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT nadjiseyedalireza nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT idaniesmaeil nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT zahirireyhaneh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT lookzadehsomayeh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT sheikhzadehakimeh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT dastanfarzaneh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT porabdollahtoutkabonimihan nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT rezaeimitrasadat nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT askarielham nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT tabarsipayam nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT marjanimajid nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT moniriafshin nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT hashemianseyedmohammadreza nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT farzaneganbehrooz nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT abtahianzahra nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT yassarifatemeh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT mansourinazanin nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT mansouridavood nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT vasheghanimaryam nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT mansourafsharbabak nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT mokhberdezfolimojtaba nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT soleimanisalman nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT seifisharareh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT naghashzadehfarah nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT fakharianatefeh nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT varahrammohammad nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT jamaatihamidreza nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT zalialireza nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 AT velayatialiakbar nationalresearchinstituteoftuberculosisandlungdiseasenritldprotocolforthetreatmentofpatientswithcovid19 |